Skip to content
Search

Latest Stories

Follow Us:
Top Stories

How the government can solve America's obesity epidemic

News

How the government can solve America's obesity epidemic
Getty Images

Pearl is a clinical professor of plastic surgery at the Stanford University School of Medicine and is on the faculty of the Stanford Graduate School of Business. He is a former CEO of The Permanente Medical Group.

Dying younger. Living harder. Going broke. It is difficult to overstate the longitudinal effects of excess weight in America.


An estimated seven in ten Americans are overweight or obese. The combination, according to the National Institutes of Health, results in an estimated 300,000 preventable deaths per year with extreme obesity lowering life expectancy by 14 years on average.

Added weight not only makes everyday life more difficult, but it also produces serious health consequences that include cardiovascular disease, diabetes, musculoskeletal disorders and cancer. In total, obesity costs an estimated $260 billion annually in inpatient and outpatient care.

Whether weight gain is caused primarily by genetics, societal influences or individual will, scientists aren’t altogether sure. What’s clear, however, is that most efforts to lose weight ultimately fail.

New Hope In Diabetes Drugs

Ozempic, one of a new class of medications, has been shown in studies to spur significant weight loss. The others include Mounjaro, Rybelsus and Wegovy with several new (and convenient, pill-based) options in development.

A Heavy Price For Weight Loss

Last year, more than five million Americans were prescribed one of these drugs for weight reduction.

The annual price of treatment ranges from $12,000 (Mounjaro) to upwards of $16,000 per year (Wegovy). As a result, most users are either wealthy or have generous health-insurance coverage.

But as more Americans seek these medications for moderate weight loss, not diabetes, insurers have started clamping down. They’ve issued threatening letters to doctors, warning they’ll be referred to state regulatory boards for writing “off-label” prescriptions.

The Ozempic Paradox: Highly Effective But Unaffordable

Ozempic and other medications that help with weight loss are part of an ongoing national debate in which two competing truths collide.

The first truth is that these drugs work, leading to significant and sustained weight reduction: 14 to 25 pounds per individual on average during the medication course. And while they’re not a replacement for proper nutrition, exercise or healthier living, they do reduce the likelihood of heart attack, stroke and cancer.

Second, despite the medical opportunity at hand, making these drugs available to all 100 million obese American adults would prove cost prohibitive for businesses, private insurers and the government.

This means that the medications could drastically rollback the nation’s $260 billion in obesity-related medical expenses each year, but prescribing them at today’s prices would cost more than $1.5 trillion annually—increasing national healthcare expenditures by as much as 25 percent.

What’s more, these medications are considered “forever drugs,” requiring users to either maintain their dosage or regain most of the weight they lost.

Insurers are eager to draw a line between those seeking prescriptions for appearance’s sake and those at heightened risk of disease or death. They’re happy to cover the latter but, as with cosmetic surgery, insurers believe patients should foot the bill for the former.

Lost in this debate is an important question: Why not figure out how to make these lifesaving drugs broadly available and affordable?

The U.S. Government Can Lead The Way

With hundreds of thousands of obesity-related deaths each year, the magnitude of the problem qualifies as an “epidemic” and justifies forceful government intervention.

The current administration, with congressional approval, could initiate a nationwide campaign to fight obesity, similar to Operation Warp Speed. The program, with a $10 billion upfront investment, led to the speedy development of a safe and effective coronavirus vaccine. The government then was able to purchase more than one billion doses at one-third the cost of the vaccine’s current list price.

Here’s how the administration could replicate Operation Warp Speed to fight the obesity epidemic without breaking the bank.

Operation: Slim Provisions

The government would invest $4 billion up front— twice the average R&D cost to bring a new drug to market.

In return for funding and a ten year contract, the first drugmaker to develop a safe and effective weight-loss drug would be required to sell that medication back to the government at $40 per dose (or $2,000 per patient/year), significantly below the retail price of Ozempic and similar drugs. The winning pharma company would benefit financially, earning up to $1.2 trillion in sales over the contract’s lifetime without having to shoulder R&D costs.

With the new medication in hand, government-sponsored health programs, Medicaid and Medicare, would make it available to all obese enrollees (roughly 60 million people) for the next decade.

And by providing the drug to more than half of all obese adults, the government would reduce medical expenses by up to $130 billion annually or $1.3 trillion over 10 years, making the effort cost-neutral for American taxpayers.

Risks vs. Rewards

The only financial risk to the government (outside of defending likely lawsuits) would be failing in its search for a new drug, thus wasting the

$4 billion of taxpayer money. But that’s a relatively insignificant sum compared to the potential healthcare benefits.

The role of government is to protect the health and financial well-being of the nation. Fulfilling that function led to a lifesaving Covid-19 vaccine. Doing so again is the best option our nation has to address America’s growing obesity epidemic.


Read More

​President Donald Trump

President Donald Trump speaks in the James S. Brady Press Briefing Room of the White House on November 09, 2026 in Washington, DC.

(Photo by Chip Somodevilla/Getty Images)

Trump’s Betrayal of Ukraine Leaves Blood on His Hands and a Stain on the Country He Leads

The Bible is filled with stories of betrayal and warnings of human treachery. Recall that Cain betrayed his brother Abel after God showed Abel his favor. Cain’s response was to lure Abel into a field where he killed him.

Or recall how Samson was betrayed by Delilah, the woman he loved. As the book of Judges says, she lured him into showing her “the secret of his great strength and how we can overpower him so we may tie him up and subdue him.” In return, she received “eleven hundred shekels of silver.”

Keep ReadingShow less
A pair of scissors cutting one hundred dollar bills
A pair of scissors cutting a continuous strip of one hundred dollar bills
Photo by Igor Omilaev on Unsplash

The Lion's Share of National Debt, Traceable to Supply-Side Economics

Tax Cut Eras (1982–2025)

From 1982 through 2025, the United States fundamentally shifted its fiscal structure through four massive, era-defining waves of tax cuts. Quantifying these legislative packages through data from the Congressional Budget Office (CBO) and the Joint Committee on Taxation (JCT) reveals a cumulative primary revenue reduction exceeding $11.5 Trillion in direct nominal costs. When accounting for the compounding interest of $4.5 Trillion required to service, the resulting federal debt, the total fiscal impact rises to $15 Trillion. Since , between fiscal years 1982 and 2025, the U.S. federal government spent a total of approximately $13.5 trillion in gross interest on the national debt, approximately 1/3 of this gross interest was attributable to supply-side tax cuts.

Keep ReadingShow less
San Francisco skyline
city buildings under blue sky during daytime
Photo by Shen Pan on Unsplash

The Razing of the Fillmore

San Francisco called itself “the City That Knows How.” The razing of the Fillmore asks what officials knew about the people whose neighborhood they were changing. Federal money helped finance local redevelopment, while families and businesses bore displacement. We should trace that money and preserve residents’ accounts before another promise of improvement escapes scrutiny.

The Fillmore remains a center of Black cultural life. Black, Japanese and Jewish communities helped shape the neighborhood, its businesses and music. People remain, and people remember. Redevelopment damaged relationships that a construction budget could neither measure nor replace. Its history belongs to surviving residents and their descendants as well as official archives.

Keep ReadingShow less
​U.S. Vice President JD Vance

U.S. Vice President JD Vance speaks to members of the media before boarding Air Force Two as he leaves Switzerland after meeting with representatives from Iran to negotiate details of their peace agreement at Emmen Air Base, near Lucerne, Switzerland, on June 22, 2026.

(Nathan Howard/Pool/AFP/Getty Images/Tribune Content Agency)

JD Vance has no idea what 2028 voters actually want

I regret to inform you that we are now one week into the 2028 presidential election cycle.

This is the stage where various factions try to shape the conventional wisdom to support their particular agenda. For Democrats, that’s a difficult process, because they so wildly overperformed in the midterms that every faction has a favorable story to tell. For Republicans, it’s tougher and uglier.

Keep ReadingShow less